Documentos de Thanos P.K. | REDI

Regresar

Mostrando 7 resultados de: 7

Filtros aplicados

Objetivos de Desarrollo Sostenible: "ODS 10: Reducción de las desigualdades"

Subtipo de publicación

Publisher

Pharmacology Biochemistry and Behavior(2)

Behavioural Brain Research(1)

Developmental Psychobiology(1)

Journal of Neural Transmission(1)

Área temáticas

Enfermedades(6)

Farmacología y terapéutica(5)

Fisiología humana(3)

Ginecología, obstetricia, pediatría, geriatría(1)

Área de conocimiento

Biología del desarrollo(1)

Farmacología(1)

Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar(7)

ODS 4: Educación de calidad(4)

ODS 2: Hambre cero(2)

ODS 5: Igualdad de género(1)

Año de Publicación

Origen

Palabras Claves

methylphenidate(6)

Attention Deficit Hyperactivity Disorder(5)

Psychostimulant(4)

A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior

Abstract: Most animal studies using methylphenidate (MP) do not administer it the same way it is administered

Palabras claves:

Attention Deficit Hyperactivity Disorder, Dopamine transporter, methylphenidate, Psychostimulant, ritalin

Cooper T., David Edward Komatsu, Hadjiargyrou M., Hwang Y., Robison L.S., Steier J., Swanson J.M., Thanos P.K., Volkow N.D.

Chronic exposure to methylphenidate impairs appendicular bone quality in young rats

Abstract: Methylphenidate (MP) is a psychostimulant widely prescribed to treat Attention Deficit Hyperactivity

Palabras claves:

Biomechanics, DXA, Growth suppression, methylphenidate, Testosterone

Ananth M., David Edward Komatsu, Hadjiargyrou M., Janda H.A., John C.M., Mary M.N., Robison L.S., Swanson J.M., Thanos P.K., Volkow N.D.

Chronic oral methylphenidate treatment increases microglial activation in rats

Abstract: Methylphenidate (MP) is a widely prescribed psychostimulant used to treat attention deficit hyperact

Palabras claves:

Attention Deficit Hyperactivity Disorder, Autoradiography, inflammation, methylphenidate, Microglia, ritalin

Carias E., David Edward Komatsu, Delis F., Eiden R., Hadjiargyrou M., Hamilton J., Quattrin T., Robison L.S., Thanos P.K.

Brief and extended abstinence from chronic oral methylphenidate treatment produces reversible behavioral and physiological effects

Abstract: Methylphenidate (MP) is a commonly prescribed psychostimulant to individuals with Attention Deficit

Palabras claves:

anxiety, Attention Deficit Hyperactivity Disorder, methylphenidate, Psychostimulant, ritalin

Carias E., Connor C., David Edward Komatsu, Hadjiargyrou M., Kalinowski L., Mackintosh M., Martin C., Popoola D., Richer K., Smith L., Somanesan R., Thanos P.K.

Recovery from behavior and developmental effects of chronic oral methylphenidate following an abstinence period

Abstract: Chronic oral methylphenidate (MP) exposure in rats is associated with numerous developmental and beh

Palabras claves:

anxiety, Attention Deficit Hyperactivity Disorder, methylphenidate, Psychostimulant, ritalin, Sensitization

David Edward Komatsu, Fricke D., Hadjiargyrou M., Koutsomitis D., Lowinger C., Martin C., Popoola D., Thanos P.K., Vijayashanthar A.

Methylphenidate regulation of osteoclasts in a dose- A nd sex-dependent manner adversely affects skeletal mechanical integrity

Abstract: Methylphenidate (MP) is the most prescribed psychostimulant for ADHD patients, with clinically demon

Palabras claves:

Chernoff E., David Edward Komatsu, Fricke D., Hadjiargyrou M., Robison L.S., Thanos P.K., Uddin S.M.Z.

Weekday-only chronic oral methylphenidate self-administration in male rats: Reversibility of the behavioral and physiological effects

Abstract: Methylphenidate (MP) is a commonly prescribed psychostimulant for Attention Deficit Hyperactivity Di

Palabras claves:

anxiety, Attention Deficit Hyperactivity Disorder, Depression, methylphenidate, Psychostimulant, ritalin, SOCIAL BEHAVIOR

Carias E., David Edward Komatsu, Fricke D., Hadjiargyrou M., Kalinowski L., Martin C., Popoola D., Smith L., Somanesan R., Thanos P.K., Vijayashanthar A.